Author(s): Inaba H, Hale G, Leung W, Woodard P, Burnette K, , Inaba H, Hale G, Leung W, Woodard P, Burnette K,
Abstract Share this page
Abstract Engraftment syndrome, autologous graft-versus-host disease (GVHD), and infection after autologous hematopoietic cell transplantation can have similar clinical presentations. Here, we describe a patient with refractory Ewing sarcoma who had recurrent skin rash after autologous hematopoietic cell transplantation. Although the rash was diagnosed as GVHD histologically, this case illustrates the diagnostic dilemma of distinguishing engraftment syndrome, autologous GVHD, or concomitant viral infection. Because therapy for these entities is different, distinguishing them is important. Establishment of diagnostic criteria and understanding of the pathophysiology of these entities may lead to better management and to improved therapy of refractory cancer.
This article was published in J Pediatr Hematol Oncol
and referenced in Journal of Bone Research